PubMed · 11194352
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
G Häusser-Fruh. 2000. [Tegaserod].. https://pubmed.ncbi.nlm.nih.gov/11194352/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Irritable bowel syndrome is a chronic, relapsing functional bowel disorder of unknown aetiology. Methods of studying intestinal motor function, nociception, and interactions of the central nervous system and enteric nervous system are not applicable for clinical use. The diagnosis is therefore made on the symptoms, but it is necessary to exclude relevant organic disease. Establishment of the diagnosis, information about the disorder, elimination of foods and other factors that provoke the symptoms, and a change in life-style are sufficient in most cases. Treatment is hampered by the lack of effective treatment and the psychological aspects. The therapeutic gain of drug administration is modest and the rate of response to placebo is high. Fibre supplementation, magnesium oxide or cisapride may be tried for constipation, diphenoxylate or loperamide for diarrhoea, and low dose tricyclic antidepressants or serotonin reuptake blockers for severe pain. The introduction of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists seems promising.
Explore the source record for details and available documents.
Explore the source record for details and available documents.